Aarti Drugs (BOM:524348) Interest Expense : ₹-335 Mil (TTM As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aarti Drugs's interest expense for the three months ended in Mar. 2024 was ₹ -91 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-335 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Aarti Drugs's Operating Income for the three months ended in Mar. 2024 was ₹ 722 Mil. Aarti Drugs's Interest Expense for the three months ended in Mar. 2024 was ₹ -91 Mil. Aarti Drugs's Interest Coverage for the quarter that ended in Mar. 2024 was 7.91. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aarti Drugs Interest Expense Historical Data

The historical data trend for Aarti Drugs's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs Interest Expense Chart

Aarti Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-337.26

-229.57

-207.48

-332.90

-335.20

Aarti Drugs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-86.30	-85.40	-82.50	-76.00	-91.30

Aarti Drugs Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-335 Mil.

Aarti Drugs (BOM:524348) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aarti Drugs's Interest Expense for the three months ended in Mar. 2024 was ₹-91 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹722 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₹2,762 Mil.

Aarti Drugs's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	722.2	/	-91.3
	=	7.91

The higher the ratio, the stronger the company's financial strength is.

Aarti Drugs (BOM:524348) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Interest Expense

Traded in Other Exchanges

AARTIDRUGS:India

Address

Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400 022

Website

https://www.aartidrugs.co.in

Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.

Aarti Drugs (BOM:524348) Headlines

No Headlines